Abstract
Biomedical applications of various Cellulosics have been reviewed and their interaction with blood is discussed. A new haemostatic agent 2,3,6-tricarboxy cellulose “Supercel” has been produced by NO2 oxidation of 2,3-dialdehyde cellulose and a possible mechanism for blood clotting initiated by Supercel is presented.